Unraveling genetic predisposition and oxidative stress in vitiligo development and the role of artificial intelligence (AI) in diagnosis and management:

Hristina Kocic; Torello Lotti; Tatjana Jevtovic-Stoimenov; Uwe Wollina; Yan  Valle; Stevo Lukic; Aleksandra Klisic

doi:10.5937/jomb0-56661

Unraveling genetic predisposition and oxidative stress in vitiligo development and the role of artificial intelligence (AI) in diagnosis and management

Artificial intelligence (AI) in the diagnosis and management of vitiligo

Hristina Kocic Clinic for Dermatology University Clinical Center Nis, Medical Faculty University of Nis, Nis, Serbia
Torello Lotti Dipartimento di Scienze dela Comunicazione, Università degli Studi Guglielmo Marconi, Rome, Italy
Tatjana Jevtovic-Stoimenov Department of Biochemistry, Medical Faculty University of Nis, Nis, Serbia
Uwe Wollina Department of Dermatology and Allergology, Municipal Hospital Dresden, Academic Teaching Hospital, Dresden, Germany
Yan Valle Vitiligo Research Foundation New York, USA
Stevo Lukic Neurology Department, Faculty of Medicine, University of Nis, Nis, Serbia
Aleksandra Klisic

DOI: https://doi.org/10.5937/jomb0-56661

Keywords: vitiligo, artificial intelligence (AI), single nucleotide polymorphisms (SNP), melanin, oxidative stress, antioxidative enzymes

Abstract

Vitiligo is an autoimmune disorder with a complex genetic and epigenetic etiology, characterized by the progressive depigmentation of the skin. Recent advancements in artificial intelligence (AI) have greatly impacted the understanding, diagnosis, and treatment of vitiligo. The genetic basis of vitiligo is linked to multiple single nucleotide polymorphisms (SNPs) in genes associated with immune function, apoptosis, and melanogenesis, necessitating the integration of AI for more efficient diagnostic tools and personalized therapies. Genome-wide association studies (GWAS) have identified approximately 50 vitiligo-susceptibility genes, including PTPN1, PTPN22, NLRP1, FASLG, and TYR, among others. These genes influence the immune response and melanocyte function, with the transcription factor Nuclear Factor kappa B (NF-κB), playing a central role in inflammatory responses and redox signaling induced by oxidative stress, in conjunction with antioxidant enzymes such as GPx, GST, SOD, and CAT. AI technologies offer a promising avenue for diagnosing vitiligo by combining genetic, clinical, and imaging data, allowing for more accurate classification and personalized treatment strategies. By analyzing vast datasets, AI algorithms can identify patterns within complex genetic markers and clinical features, facilitating earlier and more precise detection of vitiligo. Furthermore, AI-driven approaches can optimize therapeutic monitoring, enabling real-time assessment of treatment efficacy and disease progression. The integration of AI in vitiligo genetic diagnostics holds the potential to revolutionize the way the disorder can be monitored, improving patient outcomes through personalized, data-driven interventions.

Published

2025/03/10

Issue

Vol. 44 No. 4 (2025): Journal of Medical Biochemistry

Section

Review article

This work is licensed under a Creative Commons Attribution 4.0 International License.

The published articles will be distributed under the Creative Commons Attribution 4.0 International License (CC BY). It is allowed to copy and redistribute the material in any medium or format, and remix, transform, and build upon it for any purpose, even commercially, as long as appropriate credit is given to the original author(s), a link to the license is provided and it is indicated if changes were made. Users are required to provide full bibliographic description of the original publication (authors, article title, journal title, volume, issue, pages), as well as its DOI code. In electronic publishing, users are also required to link the content with both the original article published in Journal of Medical Biochemistry and the licence used.

Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.